Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Oct;13(10):988-96.
doi: 10.1016/j.jpain.2012.07.007.

Geographic variation in opioid prescribing in the U.S

Affiliations

Geographic variation in opioid prescribing in the U.S

Douglas C McDonald et al. J Pain. 2012 Oct.

Abstract

Estimates of geographic variation among states and counties in the prevalence of opioid prescribing are developed using data from a large (135 million) representative national sample of opioid prescriptions dispensed during 2008 by 37,000 retail pharmacies. Statistical analyses are used to estimate the extent to which county variation is explained by characteristics of resident populations, their healthcare utilization, proxy measures of morbidity, availability of healthcare resources, and prescription monitoring laws. Geographic variation in prevalence of prescribed opioids is large, greater than the variation observed for other healthcare services. Counties having the highest prescribing rates for opioids were disproportionately located in Appalachia and in southern and western states. The number of available physicians was by far the strongest predictor of amounts prescribed, but only one-third of county variation is explained by the combination of all measured factors. Wide variation in prescribing opioids reflects weak consensus regarding the appropriate use of opioids for treating pain, especially chronic noncancer pain. Patients' demands for treatment have increased, more potent opioids have become available, an epidemic of abuse has emerged, and calls for increased government regulation are growing. Greater guidance, education, and training in opioid prescribing are needed for clinicians to support appropriate prescribing practices.

Perspective: Wide geographic variation that does not reflect differences in the prevalence of injuries, surgeries, or conditions requiring analgesics raises questions about opioid prescribing practices. Low prescription rates may indicate undertreatment, while high rates may indicate overprescribing and insufficient attention to risks of misuse.

PubMed Disclaimer

Conflict of interest statement

Disclosures

Prescription LRx Data, 2008 was obtained by Abt Associates under license from IMS Health Incorporated; all rights reserved. County location of prescribers’ offices obtained from Physician Professional Data, 2008, American Medical Association; all rights reserved. None of the authors has any institutional or personal conflict of interest. Authors had full access to all of the data in the study and are responsible for the integrity of the data and the accuracy of the analyses. The statements, findings, conclusions, views, and opinions contained and expressed herein are not necessarily those of Abt Associates Inc., the National Institutes of Health, the National Institute on Drug Abuse, or IMS Health Incorporated or any of its affiliated or subsidiary entities.

Figures

Figure 1
Figure 1
Variation among counties in mean milligrams of opioids (in morphine equivalents) dispensed by retail pharmacies, per county resident, 2008 Note: Variation is measured as difference between mean amount in milligrams in all counties and amounts prescribed and dispensed in each single county. Milligrams per resident are standardized by age and gender. Sources: Prescription data LRx Data, 2008, obtained under license from IMS Health Incorporated. All rights reserved. County location of prescribers’ offices obtained from Physician Professional Data, 2008, American Medical Association. All rights reserved. See table 3 below for sources of data on population characteristics.

References

    1. Ballantyne JC. Opioid controls: regulate to educate. Pain Med. 2010;11:480–481. - PubMed
    1. Caudill-Slosberg MA, Schwartz LM, Woloshin S. Office visits and analgesic prescriptions for musculoskeletal pain in US: 1980 vs. 2000. Pain. 2004;109:514–519. - PubMed
    1. Centers for Disease Control and Prevention: Unintentional Drug Poisoning in the United States. 2010.
    1. Centers for Disease Control and Prevention: CDC health disparities and inequalities report – United States, 2011. 2011. - PubMed
    1. Chou R, Ballantyne JC, Fanciullo GJ, Fine PG, Miaskowski C. Research gaps on use of opioids for chronic noncancer pain: findings from a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline. J Pain. 2009;10:147–159. - PubMed

Publication types

MeSH terms

Substances